| 1 |
Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies [J]. Neurology, 2017, 88(3): 296-303.
|
| 2 |
Kalilani L, Sun X, Pelgrims B, et al. The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis [J]. Epilepsia, 2018, 59(12): 2179-2193.
|
| 3 |
West S, Nevitt SJ, Cotton J, et al. Surgery for epilepsy [J]. Cochrane Database Syst Rev, 2019, 6(6): Cd010541.
|
| 4 |
Ryvlin P, Cross JH, Rheims S. Epilepsy surgery in children and adults [J]. Lancet Neurol, 2014, 13(11): 1114-1126.
|
| 5 |
蔡立新, 陈佳, 陈倩, 等. 癫痫外科治疗术前评估规范(草案) [J]. 癫痫杂志, 2020, 6(4): 273-295.
|
| 6 |
Scerri T, Riseley JR, Gillies G, et al. Familial cortical dysplasia type ⅡA caused by a germline mutation in DEPDC5 [J]. Ann Clin Transl Neurol, 2015, 2(5): 575-580.
|
| 7 |
Kasperaviciute D, Catarino CB, Matarin M, et al. Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A [J]. Brain, 2013, 136(Pt 10): 3140-3150.
|
| 8 |
Blumcke I, Spreafico R, Haaker G, et al. Histopathological findings in brain tissue obtained during epilepsy surgery [J]. N Engl J Med, 2017, 377(17): 1648-1656.
|
| 9 |
Lee JH, Huynh M, Silhavy JL, et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly [J]. Nat Genet, 2012, 44(8): 941-945.
|
| 10 |
Poduri A, Evrony GD, Cai X, et al. Somatic activation of AKT3 causes hemispheric developmental brain malformations [J]. Neuron, 2012, 74(1): 41-48.
|
| 11 |
Jansen LA, Mirzaa GM, Ishak GE, et al. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia [J]. Brain, 2015, 138(Pt 6): 1613-1628.
|
| 12 |
Leventer RJ, Scerri T, Marsh AP, et al. Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR [J]. Neurology, 2015, 84(20): 2029-2032.
|
| 13 |
Nakashima M, Saitsu H, Takei N, et al. Somatic Mutations in the MTOR gene cause focal cortical dysplasia type Ⅱb [J]. Ann Neurol, 2015, 78(3): 375-386.
|
| 14 |
Griffin NG, Cronin KD, Walley NM, et al. Somatic uniparental disomy of Chromosome 16p in hemimegalencephaly [J]. Cold Spring Harb Mol Case Stud, 2017, 3(5): a001735..
|
| 15 |
Baldassari S, Ribierre T, Marsan E, et al. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study [J]. Acta Neuropathol, 2019, 138(6): 885-900.
|
| 16 |
Pelorosso C, Watrin F, Conti V, et al. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy [J]. Hum Mol Genet, 2019, 28(22): 3755-3765.
|
| 17 |
Salinas V, Vega P, Piccirilli MV, et al. Identification of a somatic mutation in the RHEB gene through high depth and ultra-high depth next generation sequencing in a patient with Hemimegalencephaly and drug resistant Epilepsy [J]. Eur J Med Genet, 2019, 62(11): 103571.
|
| 18 |
Lee WS, Stephenson SEM, Pope K, et al. Genetic characterization identifies bottom-of-sulcus dysplasia as an mTORopathy [J]. Neurology, 2020, 95(18): e2542-e2551.
|
| 19 |
Thom M. Review: Hippocampal sclerosis in epilepsy: a neuropathology review [J]. Neuropathol Appl Neurobiol, 2014, 40(5): 520-543.
|
| 20 |
Shinnar S. Febrile Seizures and Mesial Temporal Sclerosis [J]. Epilepsy Curr, 2003, 3(4): 115-118.
|
| 21 |
Walker MC. Hippocampal Sclerosis: Causes and Prevention [J]. Semin Neurol, 2015, 35(3): 193-200.
|
| 22 |
Vezyroglou A, Varadkar S, Bast T, et al. Focal epilepsy in SCN1A-mutation carrying patients: is there a role for epilepsy surgery? [J]. Dev Med Child Neurol, 2020, 62(11): 1331-1335.
|
| 23 |
Skjei KL, Church EW, Harding BN, et al. Clinical and histopathological outcomes in patients with SCN1A mutations undergoing surgery for epilepsy [J]. J Neurosurg Pediatr, 2015, 16(6): 668-674.
|
| 24 |
Scheffer IE, Harkin LA, Grinton BE, et al. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations [J]. Brain, 2007, 130(Pt 1): 100-109.
|
| 25 |
Xiong W, Tang L, Lu L, et al. Gap Activity TOward Rags 1 variants in Chinese people with sporadic drug-resistant focal epilepsy [J]. Acta Neurol Scand, 2019, 139(3): 247-253.
|
| 26 |
Wouters H, Fonteyne A, Lagae L, et al. Specific memory impairment in a multiple disabled male with fragile X syndrome and temporal lobe epilepsy [J]. Dev Med Child Neurol, 2006, 48(5): 378-382.
|
| 27 |
Kenmuir C, Richardson M, Ghearing G. Surgical treatment for medically refractory focal epilepsy in a patient with fragile X syndrome [J]. Brain Dev, 2015, 37(9): 916-918.
|
| 28 |
Liu JY, Kasperavičiūtė D, Martinian L, et al. Neuropathology of 16p13.11 deletion in epilepsy [J]. PLoS One, 2012, 7(4): e34813.
|
| 29 |
Catarino CB, Kasperavičiūtė D, Thom M, et al. Genomic microdeletions associated with epilepsy: not a contraindication to resective surgery [J]. Epilepsia, 2011, 52(8): 1388-1392.
|
| 30 |
Johnson J, Mercado-Ayon E, Mercado-Ayon Y, et al. Mitochondrial dysfunction in the development and progression of neurodegenerative diseases [J]. Arch Biochem Biophys, 2021, 702: 108698.
|
| 31 |
Lu B, Guo S. Mechanisms linking mitochondrial dysfunction and proteostasis failure [J]. Trends Cell Biol, 2020, 30(4): 317-328.
|
| 32 |
Azakli H, Gurses C, Arikan M, et al. Whole mitochondrial DNA variations in hippocampal surgical specimens and blood samples with high-throughput sequencing: a case of mesial temporal lobe epilepsy with hippocampal sclerosis [J]. Gene, 2013, 529(1): 190-194.
|
| 33 |
Niehusmann P, Surges R, Von Wrede RD, et al. Mitochondrial dysfunction due to Leber's hereditary optic neuropathy as a cause of visual loss during assessment for epilepsy surgery [J]. Epilepsy Behav, 2011, 20(1): 38-43.
|
| 34 |
Blumcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission [J]. Epilepsia, 2011, 52(1): 158-174.
|
| 35 |
Bar-Peled L, Chantranupong L, Cherniack AD, et al. A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1 [J]. Science, 2013, 340(6136): 1100-1106.
|
| 36 |
Baulac S, Ishida S, Marsan E, et al. Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations [J]. Ann Neurol, 2015, 77(4): 675-683.
|
| 37 |
Carvill GL, Crompton DE, Regan BM, et al. Epileptic spasms are a feature of DEPDC5 mTORopathy [J]. Neurol Genet, 2015, 1(2): e17.
|
| 38 |
Baldassari S, Picard F, Verbeek NE, et al. The landscape of epilepsy-related GATOR1 variants [J]. Genet Med, 2019, 21(2): 398-408.
|
| 39 |
Lee WS, Stephenson SEM, Howell KB, et al. Second-hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type ⅡA [J]. Ann Clin Transl Neurol, 2019, 6(7): 1338-1344.
|
| 40 |
Ying Z, Wang I, Blumcke I, et al. A comprehensive clinico-pathological and genetic evaluation of bottom-of-sulcus focal cortical dysplasia in patients with difficult-to-localize focal epilepsy [J]. Epileptic Disord, 2019, 21(1): 65-77.
|
| 41 |
Sim JC, Scerri T, Fanjul-Fernández M, et al. Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3 [J]. Ann Neurol, 2016, 79(1): 132-137.
|
| 42 |
Weckhuysen S, Marsan E, Lambrecq V, et al. Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia [J]. Epilepsia, 2016, 57(6): 994-1003.
|
| 43 |
Liu S, Yu T, Guan Y, et al. Resective epilepsy surgery in tuberous sclerosis complex: a nationwide multicentre retrospective study from China [J]. Brain, 2020, 143(2): 570-581.
|
| 44 |
Barba C, Parrini E, Coras R, et al. Co-occurring malformations of cortical development and SCN1A gene mutations [J]. Epilepsia, 2014, 55(7): 1009-1019.
|
| 45 |
Strauss KA, Puffenberger EG, Huentelman MJ, et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2 [J]. N Engl J Med, 2006, 354(13): 1370-1377.
|
| 46 |
Rubboli G, Plazzi G, Picard F, et al. Mild malformations of cortical development in sleep-related hypermotor epilepsy due to KCNT1 mutations [J]. Ann Clin Transl Neurol, 2019, 6(2): 386-391.
|
| 47 |
Kurian M, Korff CM, Ranza E, et al. Focal cortical malformations in children with early infantile epilepsy and PCDH19 mutations: case report [J]. Dev Med Child Neurol, 2018, 60(1): 100-105.
|
| 48 |
Weckhuysen S, Holmgren P, Hendrickx R, et al. Reduction of seizure frequency after epilepsy surgery in a patient with STXBP1 encephalopathy and clinical description of six novel mutation carriers [J]. Epilepsia, 2013, 54(5): e74-80.
|
| 49 |
Rosenow F, Alonso-Vanegas MA, Baumgartner C, et al. Cavernoma-related epilepsy: review and recommendations for management--report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies [J]. Epilepsia, 2013, 54(12): 2025-2035.
|
| 50 |
Baumann CR, Acciarri N, Bertalanffy H, et al. Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients [J]. Epilepsia, 2007, 48(3): 559-563.
|
| 51 |
Graeni C, Stepper F, Sturzenegger M, et al. Inherited cavernous malformations of the central nervous system: clinical and genetic features in 19 Swiss families [J]. Neurosurg Rev, 2010, 33(1): 47-51.
|
| 52 |
Gault J, Shenkar R, Recksiek P, et al. Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion [J]. Stroke, 2005, 36(4): 872-874.
|
| 53 |
Nannucci S, Pescini F, Poggesi A, et al. Familial cerebral cavernous malformation: report of a further Italian family [J]. Neurol Sci, 2009, 30(2): 143-147.
|
| 54 |
Wang X, Liu XW, Lee N, et al. Features of a Chinese family with cerebral cavernous malformation induced by a novel CCM1 gene mutation [J]. Chin Med J (Engl), 2013, 126(18): 3427-3432.
|
| 55 |
Fontes-Dantas FL, Da Fontoura Galvão G, Veloso Da Silva E, et al. Novel CCM1 (KRIT1) mutation detection in brazilian familial cerebral cavernous malformation: different genetic variants in inflammation, oxidative stress, and drug metabolism genes affect disease aggressiveness [J]. World Neurosurg, 2020, 138: 535-540. e8.
|
| 56 |
Da Fontoura Galvão G, Veloso Da Silva E, Fontes-Dantas FL, et al. First report of concomitant pathogenic mutations within MGC4607/CCM2 and KRIT1/CCM1 in a familial cerebral cavernous malformation patient [J]. World Neurosurg, 2020, 142: 481-486.e1.
|
| 57 |
D'angelo R, Scimone C, Calabrò M, et al. Identification of a novel CCM2 gene mutation in an Italian family with multiple cerebral cavernous malformations and epilepsy: a causative mutation? [J]. Gene, 2013, 519(1): 202-207.
|
| 58 |
Ishii K, Tozaka N, Tsutsumi S, et al. Familial cerebral cavernous malformation presenting with epilepsy caused by mutation in the CCM2 gene: A case report [J]. Medicine (Baltimore), 2020, 99(29): e19800.
|
| 59 |
Cigoli MS, Avemaria F, De Benedetti S, et al. PDCD10 gene mutations in multiple cerebral cavernous malformations [J]. PLoS One, 2014, 9(10): e110438.
|
| 60 |
Kerrigan JF, Parsons A, Tsang C, et al. Hypothalamic hamartoma: Neuropathology and epileptogenesis [J]. Epilepsia, 2017, 58 Suppl 2: 22-31.
|
| 61 |
Fujita A, Higashijima T, Shirozu H, et al. Pathogenic variants of DYNC2H1, KIAA0556, and PTPN11 associated with hypothalamic hamartoma [J]. Neurology, 2019, 93(3): e237-e251.
|
| 62 |
Craig DW, Itty A, Panganiban C, et al. Identification of somatic chromosomal abnormalities in hypothalamic hamartoma tissue at the GLI3 locus [J]. Am J Hum Genet, 2008, 82(2): 366-374.
|
| 63 |
Wallace RH, Freeman JL, Shouri MR, et al. Somatic mutations in GLI3 can cause hypothalamic hamartoma and gelastic seizures [J]. Neurology, 2008, 70(8): 653-655.
|
| 64 |
Hildebrand MS, Griffin NG, Damiano JA, et al. Mutations of the sonic hedgehog pathway underlie hypothalamic hamartoma with gelastic epilepsy [J]. Am J Hum Genet, 2016, 99(2): 423-429.
|
| 65 |
Rubino S, Qian J, Pinheiro-Neto CD, et al. A familial syndrome of hypothalamic hamartomas, polydactyly, and SMO mutations: a clinical report of 2 cases [J]. J Neurosurg Pediatr, 2018, 23(1): 98-103.
|
| 66 |
Li CD, Luo SQ, Tang J, et al. Classification of hypothalamic hamartoma and prognostic factors for surgical outcome [J]. Acta Neurol Scand, 2014, 130(1): 18-26.
|
| 67 |
Boerwinkle VL, Foldes ST, Torrisi SJ, et al. Subcentimeter epilepsy surgery targets by resting state functional magnetic resonance imaging can improve outcomes in hypothalamic hamartoma [J]. Epilepsia, 2018, 59(12): 2284-2295.
|
| 68 |
Ferrand-Sorbets S, Fohlen M, Delalande O, et al. Seizure outcome and prognostic factors for surgical management of hypothalamic hamartomas in children [J]. Seizure, 2020, 75: 28-33.
|
| 69 |
Qi XL, Yao K, Duan ZJ, et al. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy] [J]. Zhonghua Bing Li Xue Za Zhi, 2018, 47(9): 664-670.
|
| 70 |
Slegers RJ, Blumcke I. Low-grade developmental and epilepsy associated brain tumors: a critical update 2020 [J]. Acta Neuropathol Commun, 2020, 8(1): 27.
|
| 71 |
Ko A, Kim SH, Kim SH, et al. Epilepsy surgery for children with low-grade epilepsy-associated tumors: factors associated with seizure recurrence and cognitive function [J]. Pediatr Neurol, 2019, 91: 50-56.
|
| 72 |
Qaddoumi I, Orisme W, Wen J, et al. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology [J]. Acta Neuropathol, 2016, 131(6): 833-845.
|
| 73 |
Gilboa T, Segel R, Zeligson S, et al. Ganglioglioma, Epilepsy, and Intellectual Impairment due to Familial TSC1 Deletion [J]. J Child Neurol, 2018, 33(7): 482-486.
|
| 74 |
Pekmezci M, Villanueva-Meyer JE, Goode B, et al. The genetic landscape of ganglioglioma [J]. Acta Neuropathol Commun, 2018, 6(1): 47.
|
| 75 |
Rivera B, Gayden T, Carrot-Zhang J, et al. Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors [J]. Acta Neuropathol, 2016, 131(6): 847-863.
|
| 76 |
Stone TJ, Keeley A, Virasami A, et al. Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours [J]. Acta Neuropathol, 2018, 135(1): 115-129.
|
| 77 |
Martinoni M, Marucci G, De Biase D, et al. BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas [J]. J Clin Neurosci, 2015, 22(8): 1250-1253.
|
| 78 |
Kakkar A, Majumdar A, Pathak P, et al. BRAF gene alterations and enhanced mammalian target of rapamycin signaling in gangliogliomas [J]. Neurol India, 2017, 65(5): 1076-1082.
|
| 79 |
Zhang YX, Shen CH, Guo Y, et al. BRAF V600E mutation in epilepsy-associated glioneuronal tumors: Prevalence and correlation with clinical features in a Chinese population [J]. Seizure, 2017, 45: 102-106.
|